This is a non-core endpoint: only basic statistics are computed.
Secondary malignant neoplasm of other and unspecified sites
C3_SECONDARY_NAS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
694 |
4. Check minimum number of eventsNone |
694 |
5. Include endpointsNone |
694 |
6. Filter based on genotype QC (FinnGen only) |
677 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Secondary malignant neoplasm of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm
- Secondary malignant neoplasm of other and unspecified sites, including Hilmo
- Any death
- Solid cancers
- Malignant neoplasm
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 677 | 290 | 387 |
| Unadjusted period prevalence (%) | 0.15 | 0.10 | 0.18 |
| Median age at first event (years) | 73.10 | 70.92 | 74.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 694
- Matched controls
- 6940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A03FA01
ATC
metoclopramide; systemic, rectal
31.5
307.7
477
453
XX3DW
NOMESCO Finland
Time consuming IT work
40.6
307.7
334
155
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
307.7
375
*
Z51.5
ICD-10 Finland
Palliative care
65.7
307.7
425
163
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
378
*
H02AB02
ATC
dexamethasone; systemic
408.5
307.7
468
35
WF049
NOMESCO Finland
Radiotherapy of metastasis
5523.5
307.7
326
*
JN4BD
NOMESCO Finland
Extensive body CT
34.5
307.7
300
150
N02AA05
ATC
oxycodone; systemic
19.4
307.7
479
716
JN4AD
NOMESCO Finland
Body CT examination
18.8
301.9
292
258
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
298.1
264
*
A04AA01
ATC
ondansetron; systemic, rectal
35.7
279.1
185
70
A04AA02
ATC
granisetron; systemic, transdermal
1860.5
268.0
243
*
WZC00
NOMESCO Finland
Treatment plan or consultation
13.1
244.7
513
1238
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
35.7
235.4
154
55
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3098.0
222.2
203
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
217.5
197
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1388.1
215.6
199
*
M05BX04
ATC
denosumab; parenteral
14.8
204.8
211
199
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
182.6
167
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
159.7
147
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
1888.6
158.7
148
*
JN4CD
NOMESCO Finland
Very extensive body CT
32.7
152.9
101
36
L01BC06
ATC
capecitabine; oral
+∞
150.7
139
*
116
Kela drug reimbursment
Prostate cancer
+∞
147.3
136
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
20.9
135.6
107
60
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
406.5
134.6
131
*
A06AH03
ATC
naloxegol; oral
67.9
132.6
73
12
WW500
NOMESCO Finland
Blood transfusion
19.9
125.4
101
59
115
Kela drug reimbursment
Breast cancer
+∞
122.6
114
*
WZC30
NOMESCO Finland
Teaching
6.5
113.8
242
525
NK6AN
NOMESCO Finland
Total body bone isotope imaging
315.6
108.2
107
*
L03AA13
ATC
pegfilgrastim; parenteral
559.2
100.2
97
*
L02AE02
ATC
leuprorelin; implant, parenteral
284.7
98.4
98
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
96.1
90
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
95.0
89
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
355.3
93.3
92
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
15.8
92.7
83
59
L02BG04
ATC
letrozole; oral
499.4
90.4
88
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
14.9
88.4
82
62
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
87.4
82
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
87.4
82
*
WF002
NOMESCO Finland
Radical radiotherapy
198.5
85.3
87
5
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
26.8
84.5
59
24
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
84.1
79
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
84.1
79
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
84.1
79
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
84.1
79
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
81.9
77
*
Y77
ICPC
Malignant neoplasm prostate
875.2
81.1
78
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
862.6
80.1
77
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
79.7
75
*
JN6AD
NOMESCO Finland
CT of torso and neck
35.8
78.8
50
15
HA1AA
NOMESCO Finland
X-ray mammography
10.8
75.2
86
90
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
19.4
74.0
59
33
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.2
73.1
185
454
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
762.8
71.4
69
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
71.1
67
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
71.1
67
*
L02BB04
ATC
enzalutamide; oral
+∞
70.0
66
*
L02BB03
ATC
bicalutamide; oral
+∞
68.9
65
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
246.7
66.4
67
*
B01AB10
ATC
tinzaparin; parenteral
5.5
66.0
147
321
A04AD12
ATC
aprepitant; systemic
+∞
62.4
59
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
62.4
59
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
61.4
58
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
60.3
57
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
60.3
57
*
L02BA01
ATC
tamoxifen; oral
323.9
59.3
59
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.8
59.1
59
50
AA1BD
NOMESCO Finland
Extensive CT of head and brain
12.8
58.1
58
49
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
58.1
55
*
N02AA01
ATC
morphine; systemic, rectal
14.6
57.6
53
39
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
605.8
57.5
56
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
57.1
54
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
56.0
53
*
L02BX03
ATC
abiraterone; oral
+∞
53.9
51
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.3
51.9
342
1583
ZX090
NOMESCO Finland
Other technic of radiotherapy
146.1
51.6
54
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
268.9
49.7
50
*
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
49.6
47
*
X76
ICPC
Malignant neoplasm breast female
+∞
48.5
46
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
47.4
45
*
L01CA04
ATC
vinorelbine; systemic
+∞
47.4
45
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
489.2
46.9
46
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.8
46.8
119
287
L02BX02
ATC
degarelix; parenteral
+∞
45.3
43
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
45.3
43
*
L02BA03
ATC
fulvestrant; parenteral
+∞
45.3
43
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
466.3
44.8
44
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
44.5
465
2722
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
44.2
42
*
A79
ICPC
Malignancy NOS
454.9
43.7
43
*
N03AX14
ATC
levetiracetam; systemic
8.2
42.6
59
78
L03AA02
ATC
filgrastim; parenteral
228.8
42.4
43
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
120.1
42.3
45
*
192
Kela drug reimbursment
Fulvestrant
+∞
42.1
40
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
15.6
41.9
37
25
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.4
41.6
120
318
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
432.2
41.6
41
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
41.0
39
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
41.0
39
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
41.0
39
*
ZX120
NOMESCO Finland
Intravenous
4.8
40.0
98
228
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.6
40.0
104
254
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
40.0
38
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
40.0
38
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
7.7
40.0
58
81
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.6
39.8
104
255
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
13.4
38.6
37
29
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
37.9
36
*
L02BG06
ATC
exemestane; oral
376.0
36.3
36
*
WW200, ,
SPAT
0.1
36.3
27
1764
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.8
36.0
125
377
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.4
35.8
75
152
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
35.7
34
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
62.1
35.6
41
7
HAB40
NOMESCO Finland
Wedge excision of mammary gland
70.5
35.4
40
6
C50.99
ICD-10 Finland
Breast, unspecified
+∞
34.7
33
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
34.7
33
*
C20
ICD-10 Finland
Malignant neoplasm of rectum
+∞
34.7
33
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
78.2
33.2
37
5
1501
Kela drug reimbursment
Palbociclib
+∞
32.6
31
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
32.6
31
*
A02BC02
ATC
pantoprazole; systemic
3.0
31.6
550
3880
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
31.5
30
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
31.5
30
*
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
+∞
31.5
30
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
30.4
29
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.1
30.4
14
1386
L02AE03
ATC
goserelin; implant
111.7
29.9
32
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
29.4
28
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
29.4
28
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
29.4
28
*
H02AB06
ATC
prednisolone; systemic
2.5
29.3
401
2479
B01AB05
ATC
enoxaparin; parenteral
2.5
28.7
278
1467
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
9.0
28.6
36
42
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
28.3
27
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
49.4
27.7
33
7
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
27.7
129
466
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
55.8
27.4
32
6
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
27.3
26
*
L01CB01
ATC
etoposide; systemic
+∞
27.3
26
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
281.4
26.9
27
*
SPAT1254
SPAT
Administration of medicine
2.8
26.7
161
671
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.6
26.6
95
290
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
26.2
25
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
26.2
25
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
26.2
25
*
TGD00
NOMESCO Finland
Needle biopsy of lung
97.2
25.8
28
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
25.3
206
993
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
25.2
24
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
25.2
24
*
394
Kela drug reimbursment
Palbociclib
+∞
25.2
24
*
ZX112
NOMESCO Finland
Subcutaneous
23.0
24.6
35
16
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
24.1
23
*
L01XE33
ATC
[U] palbociclib
+∞
24.1
23
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
24.1
23
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
24.1
23
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
24.1
23
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
5.4
23.9
49
97
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
90.0
23.8
26
*
R50.9
ICD-10 Finland
Fever, unspecified
2.8
23.5
136
551
J01MA12
ATC
levofloxacin; systemic
2.6
23.5
178
826
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.2
23.4
358
2246
EB1VA, ,
NOMESCO Finland
0.1
23.4
7
759
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
8.7
23.3
30
36
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
23.0
22
*
1523, ,
Kela drug reimbursment
+∞
23.0
22
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
23.0
22
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
23.0
22
*
3054, ,
Kela drug reimbursment
+∞
23.0
22
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
86.4
22.8
25
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
6.3
22.7
39
65
J94.8
ICD-10 Finland
Other specified pleural conditions
7.5
22.6
33
46
SPAT1109
SPAT
Analgesia with portable analgesic pump
53.9
22.2
26
5
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.0
21.8
66
179
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.5
21.5
55
131
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.5
21.2
35
56
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.2
21.0
58
147
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
20.9
20
*
L02AE04
ATC
triptorelin; parenteral
+∞
20.9
20
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
20.9
20
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
20.9
20
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
20.9
20
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
20.9
20
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
20.9
20
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
20.9
20
*
C43.5
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of trunk
+∞
20.9
20
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.8
20.6
119
480
EB4VA, ,
NOMESCO Finland
0.0
20.5
*
559
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
28.0
20.2
27
10
SPAT1255
SPAT
Intravenous administration of medicine
3.4
19.9
76
241
L02BG03
ATC
anastrozole; oral
+∞
19.9
19
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
19.9
19
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
205.6
19.7
20
*
R4110, ,
SPAT
0.1
19.4
8
688
KCD02
NOMESCO Finland
Transurethral resection of bladder
32.3
19.4
25
8
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.2
18.8
30
1235
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
18.8
18
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
18.8
18
*
WF099
NOMESCO Finland
Other radiotherapy
71.9
18.8
21
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
24.5
18.8
26
11
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
195.1
18.6
19
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
54.0
18.0
21
*
AA1AD
NOMESCO Finland
CT of head and brain
2.0
18.0
286
1772
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
5.4
17.9
36
70
197
Kela drug reimbursment
Sunitinib
+∞
17.8
17
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
17.8
17
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
17.8
17
*
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
37.8
17.7
22
6
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.4
17.7
35
67
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
97.6
17.6
19
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
184.5
17.6
18
*
R84
ICPC
Malignant neoplasm bronchus/lung
184.5
17.6
18
*
NF3AA
NOMESCO Finland
Femur X-ray examination
4.9
17.5
39
83
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
43.2
17.4
21
5
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
16.7
16
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
16.7
16
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
16.7
16
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
16.7
16
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
16.7
16
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
+∞
16.7
16
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
16.7
16
*
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
+∞
16.7
16
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.1
16.6
47
121
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
16.6
160
814
Z51.0
ICD-10 Finland
Radiotherapy session
174.0
16.6
17
*
N03AX16
ATC
[U] pregabalin
2.1
16.4
189
1032
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
13.2
16.3
28
22
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.3
16.2
24
34
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
48.7
16.1
19
*
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.8
16.0
51
143
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.9
16.0
49
134
C10AA07
ATC
rosuvastatin; oral
0.4
15.7
94
1951
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
15.7
15
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
15.7
15
*
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
15.7
15
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
15.7
15
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
15.7
15
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
15.7
15
*
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
+∞
15.7
15
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.7
15
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
15.7
15
*
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
39.0
15.4
19
5
N02BE01
ATC
paracetamol; systemic, rectal
3.1
15.3
640
5507
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
15.0
167
897
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
32.5
14.9
19
6
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.3
14.8
39
95
GD1AD
NOMESCO Finland
Thorax CT examination
3.1
14.8
64
219
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
14.6
14
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
+∞
14.6
14
*
L01XE04
ATC
[U] sunitinib
+∞
14.6
14
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
14.6
14
*
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
+∞
14.6
14
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
14.6
14
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
14.6
14
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
+∞
14.6
14
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
153.1
14.5
15
*
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.5
14.5
36
84
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
14.4
132
655
B03XA02
ATC
darbepoetin alfa; parenteral
6.6
14.2
23
36
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
43.4
14.2
17
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
6.9
14.1
22
33
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
10.4
14.1
27
27
SPAT1262
SPAT
Handing over of treatment supplies
2.1
13.8
161
877
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
13.9
13.8
23
17
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
13.6
13
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
13.6
13
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
13.6
13
*
C50.1
ICD-10 Finland
Malignant neoplasm: Central portion of breast
+∞
13.6
13
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
13.6
13
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
13.6
13
*
159
Kela drug reimbursment
Pazopanib
+∞
13.6
13
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
16.6
13.5
21
13
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
142.7
13.5
14
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
26.3
13.4
18
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.0
13.3
171
964
WZC30, ,
SPAT
0.1
12.9
5
455
D75
ICPC
Malignant neoplasm colon/rectum
51.0
12.9
15
*
JG1BG
NOMESCO Finland
MRI of rectum
71.2
12.6
14
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
71.2
12.6
14
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
12.6
321
2249
L01AX03
ATC
temozolomide; systemic
+∞
12.5
12
*
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
+∞
12.5
12
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
12.5
12
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
12.5
12
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
12.5
12
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
12.5
12
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
12.5
12
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
12.5
12
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
12.5
12
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
12.5
12
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
12.5
12
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
12.5
12
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
12.5
12
*
GDC00
NOMESCO Finland
Lobectomy of lung
132.3
12.5
13
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
132.3
12.5
13
*
D77
ICPC
Malignant digestive neopl other/NOS
132.3
12.5
13
*
XKD00
NOMESCO Finland
Uroflowmetry
2.1
12.4
142
766
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
12.3
97
449
A06AD11
ATC
lactulose; oral
2.1
12.3
134
709
C10AX09
ATC
ezetimibe; oral
0.3
12.2
32
1007
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
12.2
54
187
ZXC96
NOMESCO Finland
Robot assisted procedure
18.4
12.1
18
10
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.8
12.0
22
39
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
47.5
11.9
14
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
47.5
11.9
14
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
30.6
11.7
15
5
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
66.1
11.6
13
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
23.4
11.6
16
7
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
11.5
11
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
11.5
11
*
L01XE11
ATC
[U] pazopanib
+∞
11.5
11
*
176
Kela drug reimbursment
Regorafenib
+∞
11.5
11
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
11.5
11
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
11.5
11
*
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
11.5
11
*
180
Kela drug reimbursment
Interferon alfa
+∞
11.5
11
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
11.5
11
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
11.5
11
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
+∞
11.5
11
*
C43.7
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of lower limb, including hip
+∞
11.5
11
*
L01BC59
ATC
trifluridine, combinations; systemic
+∞
11.5
11
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
11.5
11
*
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
11.5
11
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
11.5
11
*
OAB44, ,
SPAT
0.1
11.5
6
441
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
11.5
223
1432
XX1AD
NOMESCO Finland
Other CT-examination
122.0
11.5
12
*
OAB42, ,
SPAT
0.1
11.2
10
631
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.4
11.1
41
127
C03CA01
ATC
furosemide; systemic
1.8
11.1
273
1875
SPAT1263
SPAT
Sampling
1.7
11.0
298
2102
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
44.1
10.9
13
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
44.1
10.9
13
*
S77
ICPC
Malignant neoplasm of skin
44.1
10.9
13
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
10.8
121
644
ZZR00
NOMESCO Finland
Flap of skin
18.2
10.8
16
9
TQB05
NOMESCO Finland
Puncture of skin of trunk
61.0
10.7
12
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
61.0
10.7
12
*
R18
ICD-10 Finland
Ascites
5.1
10.6
22
44
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
10.4
10
*
3016
Kela drug reimbursment
Binimetinib and encorafenib
+∞
10.4
10
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
10.4
10
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
10.4
10
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
10.4
10
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
10.4
10
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
10.4
10
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
10.4
10
*
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
10.4
10
*
1CD02, ,
NOMESCO Finland
+∞
10.4
10
*
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
+∞
10.4
10
*
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
33.1
10.4
13
*
SPAT1111
SPAT
Planning of analgesia
9.0
10.3
21
24
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
10.8
10.3
19
18
TQW40, ,
SPAT
0.1
10.3
6
409
C10AA05
ATC
atorvastatin; oral
0.6
10.3
192
2811
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.4
10.3
37
113
UKC02
NOMESCO Finland
Cystoscopy
2.0
10.1
131
734
L17
ICPC
Foot/toe symptom/complaint
0.5
10.1
87
1626
N05CF01
ATC
zopiclone; oral
1.7
10.1
239
1614
KA3EB
NOMESCO Finland
Antegrade pyelography
40.7
10.0
12
*
JFF23
NOMESCO Finland
Transversostomy
26.4
9.8
13
5
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
26.4
9.8
13
5
TDA90, ,
SPAT
0.1
9.8
5
373
L15
ICPC
Knee symptom/complaint
0.4
9.8
61
1289
D19
ICPC
Teeth/gum symptom/complaint
0.4
9.6
63
1306
KEB00
NOMESCO Finland
Biopsy of prostate
10.2
9.6
18
18
Z31.5
ICD-10 Finland
Genetic counselling
4.0
9.5
27
70
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
101.4
9.4
10
*
369
Kela drug reimbursment
Regorafenib
+∞
9.4
9
*
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
9.4
9
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
9.4
9
*
1513
Kela drug reimbursment
Binimetinib and encorafenib
+∞
9.4
9
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
9.4
9
*
L03AB05
ATC
interferon alfa-2b; parenteral
+∞
9.4
9
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
9.4
9
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
9.4
9
*
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
9.4
9
*
JN4DD
NOMESCO Finland
Scout CT scan of torso
+∞
9.4
9
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
9.4
9
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
+∞
9.4
9
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
9.4
9
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
9.4
9
*
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
+∞
9.4
9
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.5
9.4
23
53
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.5
9.4
23
53
M79.6
ICD-10 Finland
Pain in limb
0.6
9.4
149
2302
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
9.2
63
274
B01AB04
ATC
dalteparin; parenteral
3.0
9.1
40
138
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
9.1
175
1110
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.2
9.0
24
59
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
37.2
9.0
11
*
N05BA06
ATC
lorazepam; systemic, sublingual
2.7
9.0
49
190
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
24.4
8.9
12
5
SPAT1153
SPAT
Removal of sutures
1.7
8.9
231
1590
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
7.3
8.8
20
28
WZC00, ,
SPAT
0.3
8.7
22
717
J01DB01
ATC
cefalexin; oral
1.8
8.7
547
4694
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
8.7
135
800
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
8.7
113
632
JFB30
NOMESCO Finland
Right hemicolectomy
14.3
8.7
14
10
R83
ICPC
Respiratory infection other
0.3
8.7
25
759
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
8.7
330
2495
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
4.9
8.6
19
40
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
16.5
8.6
13
8
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
10.2
8.6
16
16
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
0.5
8.5
74
1392
R31
ICD-10 Finland
Unspecified haematuria
2.0
8.5
94
497
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
8.5
59
258
OAA67, ,
SPAT
0.1
8.5
*
313
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
91.1
8.4
9
*
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
91.1
8.4
9
*
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
8.4
43
162
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
8.4
26
72
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
8.3
8
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
8.3
8
*
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
+∞
8.3
8
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
8.3
8
*
L01XE23
ATC
[U] dabrafenib
+∞
8.3
8
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
8.3
8
*
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
8.3
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.3
8
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
8.3
8
*
L01BC53
ATC
tegafur, combinations; systemic
+∞
8.3
8
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
8.3
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
8.3
8
*
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
+∞
8.3
8
*
C43.4
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of scalp and neck
+∞
8.3
8
*
C43.79
ICD-10 Finland
Malignant melanoma of the lower extremity including hip or other unspecified histology
+∞
8.3
8
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
+∞
8.3
8
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
8.3
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
C43.70
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip without histology
+∞
8.3
8
*
C43.53
ICD-10 Finland
Malignant melanoma of the torso nodular
+∞
8.3
8
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
8.3
8
*
C43.50
ICD-10 Finland
Malignant melanoma of the torso without histology
+∞
8.3
8
*
3012
Kela drug reimbursment
Cabozantinib
+∞
8.3
8
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.6
8.2
19
42
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
8.1
95
512
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
33.8
8.1
10
*
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
17.4
8.1
12
7
J93.8
ICD-10 Finland
Other pneumothorax
17.4
8.1
12
7
SPAT1104
SPAT
Monitoring of emergency patient
2.4
8.1
54
232
TJF80
NOMESCO Finland
Ostomy education
22.3
8.0
11
5
K03.64
ICD-10 Finland
Dental calculus supragingival
0.5
7.7
66
1254
PJA10
NOMESCO Finland
Exploration of lymph nodes
15.2
7.7
12
8
KA1FN
NOMESCO Finland
Isotope renography
15.2
7.7
12
8
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
6.0
7.7
20
34
TJA10
NOMESCO Finland
Laparocentesis
45.5
7.7
9
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
45.5
7.7
9
*
L03
ICPC
Low back symptom/complaint
0.5
7.7
77
1387
SPAT1301
SPAT
No procedures
1.6
7.7
234
1664
XJH00
NOMESCO Finland
Transanal ultrasonography
2.4
7.7
53
231
L12
ICPC
Hand/finger symptom/complaint
0.4
7.7
31
797
OAB43, ,
SPAT
0.2
7.7
10
487
GD1AA, ,
SPAT
0.2
7.7
11
503
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
7.7
76
386
SPAT1088
SPAT
Blood transfusion
18.6
7.6
11
6
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
12.0
7.6
13
11
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.5
7.6
26
77
N05BA04
ATC
oxazepam; oral
1.7
7.6
180
1203
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
7.5
235
1682
R11
ICD-10 Finland
Nausea and vomiting
2.2
7.4
65
314
E0000UV, ,
ATC
1.6
7.4
263
1936
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.6
7.3
43
174
C16.0
ICD-10 Finland
Malignant neoplasm: Cardia
+∞
7.3
7
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
7.3
7
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
7.3
7
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
7.3
7
*
1502
Kela drug reimbursment
Cabozantinib
+∞
7.3
7
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
7.3
7
*
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
7.3
7
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
7.3
7
*
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
+∞
7.3
7
*
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
+∞
7.3
7
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
7.3
7
*
198
Kela drug reimbursment
Sorafenib
+∞
7.3
7
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
7
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
7.3
7
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
7.3
7
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
+∞
7.3
7
*
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
L01XE25
ATC
[U] trametinib
+∞
7.3
7
*
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
7.3
7
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
7.3
7
*
N06DA02
ATC
donepezil; oral
0.2
7.2
9
382
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
7.2
26
80
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
30.3
7.2
9
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.5
7.2
95
1571
ED1AA
NOMESCO Finland
Mandibular X-ray examination
20.3
7.1
10
5
E83.50
ICD-10 Finland
Hypercalcemia
6.1
7.1
18
30
JAH00
NOMESCO Finland
Laparotomy
3.7
7.1
22
61
A10BK03
ATC
empagliflozin; oral
0.3
7.1
18
584
Z71.8
ICD-10 Finland
Other specified counselling
0.5
7.1
93
1542
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
7.0
87
478
SDA03
NOMESCO Finland
Periodontal treatment
0.6
7.0
115
1792
SPAT1167
SPAT
Insertion of urinary catheter
2.8
7.0
34
125
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
7.6
6.9
15
20
R74
ICPC
Upper respiratory infection acute
0.5
6.9
58
1112
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
6.9
36
137
G47.3
ICD-10 Finland
Sleep apnoea
0.5
6.9
61
1147
NG1AA, ,
SPAT
0.1
6.9
*
229
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
9.4
6.8
13
14
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
6.2
6.8
17
28
Z01.7
ICD-10 Finland
Laboratory examination
0.4
6.8
31
756
SPAT1304
SPAT
Counselling and guidance related to ageing
2.0
6.8
74
389
SPAT1290
SPAT
Preparation of deceased person
40.5
6.8
8
*
TPX15
NOMESCO Finland
Removal of vascular injection port
40.5
6.8
8
*
R4190
NOMESCO Finland
Nutritional therapy
4.0
6.7
19
49
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
6.7
84
463
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
22.8
6.7
9
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
0.2
6.6
7
324
OAB48, ,
SPAT
0.2
6.6
6
302
HAB99
NOMESCO Finland
Other partial excision of mammary gland
10.2
6.6
12
12
C43.6
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of upper limb, including shoulder
70.5
6.4
7
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
70.5
6.4
7
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
70.5
6.4
7
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
70.5
6.4
7
*
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
7.5
6.4
14
19
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.1
6.4
17
42
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.1
6.4
17
42
K85
ICPC
Elevated blood pressure
0.5
6.4
48
958
N02BF01
ATC
gabapentin; oral
0.3
6.4
13
478
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.0
6.3
16
27
SPAT1229
SPAT
Assessment of need for aid
2.0
6.3
66
342
L01EC02
ATC
dabrafenib; oral
+∞
6.3
6
*
1509
Kela drug reimbursment
Dabrafenib (adjuvant treatment)
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
XX1XN
NOMESCO Finland
Other isotope examination
+∞
6.3
6
*
341
Kela drug reimbursment
Afatinib and gefitinib
+∞
6.3
6
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
6.3
6
*
L01EF03
ATC
abemaciclib; oral
+∞
6.3
6
*
X77
ICPC
Malignant neopl genital female other
+∞
6.3
6
*
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
+∞
6.3
6
*
3030
Kela drug reimbursment
Abemaciclib
+∞
6.3
6
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
6.3
6
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
6.3
6
*
1515, ,
Kela drug reimbursment
+∞
6.3
6
*
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
+∞
6.3
6
*
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
+∞
6.3
6
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
6.3
6
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
+∞
6.3
6
*
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
+∞
6.3
6
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
6.3
6
*
C54.1
ICD-10 Finland
Malignant neoplasm: Endometrium
+∞
6.3
6
*
L01EF01
ATC
palbociclib; oral
+∞
6.3
6
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
6.3
6
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
6.3
6
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
6.3
6
*
U77
ICPC
Malignant neopl urinary tract other
+∞
6.3
6
*
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
6.3
6
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
168
Kela drug reimbursment
Axitinib
+∞
6.3
6
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
6.3
6
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
6.3
6
*
C56
ICD-10 Finland
Malignant neoplasm of ovary
+∞
6.3
6
*
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
+∞
6.3
6
*
L01XE21
ATC
[U] regorafenib
+∞
6.3
6
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
6.3
6
*
L01EE01
ATC
trametinib; oral
+∞
6.3
6
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
6.3
6
*
8720/3-C44.7
ICD-O-3
Malignant melanoma, NOS, of skin of lower limb and hip
+∞
6.3
6
*
178
Kela drug reimbursment
Combination product containing tegafur, gimeracil and oteracil
+∞
6.3
6
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
6.3
6
*
E34.0
ICD-10 Finland
Carcinoid syndrome
+∞
6.3
6
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
6.3
6
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
6.3
6
*
L01EE03
ATC
binimetinib; oral
+∞
6.3
6
*
L01EC03
ATC
encorafenib; oral
+∞
6.3
6
*
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
+∞
6.3
6
*
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
+∞
6.3
6
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
6.3
6
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
+∞
6.3
6
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
6.3
6
*
3024
Kela drug reimbursment
Dabrafenib and trametinib (adjuvant treatment)
+∞
6.3
6
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
26.9
6.2
8
*
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
26.9
6.2
8
*
ZXD05
NOMESCO Finland
Urgent procedure
1.6
6.2
194
1377
T93
ICPC
Lipid disorder
0.2
6.2
9
350
A07AA02
ATC
nystatin; oral
2.3
6.2
45
202
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.8
6.1
18
48
WX600
NOMESCO Finland
Single shot through catheter
8.7
6.1
12
14
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
6.1
32
123
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
10.1
6.0
11
11
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
299
325
15.41
269.69
5.7
1.5
80.92
2.67
ug/l
3.12
282
242
108
70
18.09
127.51
4.7
1.6
1541.41
32.96
u/ml
1.67
100
62
596
2966
8.15
103.51
17.6
4.0
9.85
12.28
umol/l
5.37
587
2800
309
986
4.85
90.33
5.0
2.4
0.81
0.83
mmol/l
2.31
304
918
81
67
13.55
82.77
1.2
1.2
—
—
—
0
0
577
3126
6.02
80.66
19.8
6.2
4.65
4.35
e9/l
1.72
544
2666
568
3217
5.22
70.07
11.1
6.0
1.22
1.21
mmol/l
1.02
426
2775
135
267
6.04
67.54
2.1
1.7
2.84
1.96
ug/l
0.23
127
234
37
2622
0.09
64.57
1.5
1.9
1.43
1.30
mmol/l
0.58
27
2151
511
2890
3.91
57.78
8.8
5.6
1.22
1.21
mmol/l
2.25
495
2620
81
120
7.51
53.28
2.7
2.3
952.42
55.71
u/ml
1.31
74
94
521
3115
3.70
51.07
13.3
18.7
1.24
1.35
inr
5.24
481
2621
480
2735
3.45
50.77
6.2
3.9
30.68
35.47
g/l
44.69
464
2540
51
5
109.93
47.46
5.6
1.0
94.80
15.80
u/ml
—
51
5
55
58
10.21
47.43
1.1
1.1
—
—
—
0
0
371
1907
3.03
45.15
3.3
2.3
51.62
61.64
u/l
2.46
355
1755
387
2078
2.95
42.76
6.8
2.1
2.32
2.35
mmol/l
3.72
368
1803
625
4518
4.86
39.80
21.1
5.7
124.48
77.27
u/l
13.67
609
4207
34
23
15.49
38.46
3.1
1.7
10.14
3.20
nmol/l
1.29
34
23
549
3716
3.28
37.29
6.6
4.8
6.83
6.85
mmol/l
0.05
536
3544
432
5691
0.36
34.60
5.3
7.4
41.78
40.40
mmol/mol
0.64
375
5280
426
2614
2.63
33.13
3.5
2.5
—
—
estimate
—
0
0
61
117
5.62
30.85
1.2
1.4
—
—
—
0
0
425
2665
2.53
30.62
4.5
4.3
37.94
90.73
ng/l
1.17
386
2063
163
650
2.97
29.55
5.7
3.2
—
—
—
0
0
236
1145
2.61
29.24
2.0
1.9
—
—
—
0
0
546
3950
2.79
27.74
5.3
4.7
65.93
2955.27
e6/l
1.74
15
64
476
5893
0.39
27.30
3.6
6.6
2.65
2.54
mmol/l
1.72
410
5413
455
5735
0.40
26.94
3.4
5.6
1.41
1.44
mmol/l
0.79
392
5234
463
5788
0.40
26.61
3.4
5.7
4.53
4.43
mmol/l
1.11
401
5325
62
140
4.76
25.99
1.2
1.4
—
—
—
0
0
79
216
4.00
25.88
2.4
3.2
—
—
—
0
0
86
254
3.72
25.23
2.1
1.7
—
—
—
0
0
48
92
5.53
24.23
1.2
1.4
—
—
—
0
0
58
133
4.67
23.84
1.2
1.4
—
—
—
0
0
100
345
3.22
22.96
1.5
1.5
—
—
—
0
0
79
240
3.59
22.16
2.1
1.6
—
—
—
0
0
43
86
5.26
20.70
1.4
1.4
34.01
27.11
g/l
2.46
43
76
30
44
7.08
19.66
1.4
1.8
24.44
23.35
ng/l
0.06
30
44
57
153
3.97
19.07
1.7
1.6
—
—
—
0
0
99
395
2.76
17.37
2.7
3.6
2.73
2.23
mmol/l
0.46
76
293
34
65
5.45
17.18
1.3
1.4
16960.40
151479.91
e6/l
0.67
25
34
35
69
5.29
17.10
1.2
1.4
—
—
—
0
0
16
0
+∞
16.73
1.1
0.0
—
—
—
0
0
139
2507
0.44
16.55
2.5
3.5
6.73
7.40
mmol/l
1.19
108
2113
101
420
2.64
16.31
1.6
1.5
—
—
—
0
0
454
5501
0.49
16.16
3.2
4.8
1.33
1.26
mmol/l
1.35
387
4971
22
9
25.17
16.08
1.7
2.0
2.30
1.78
%
—
22
9
28
48
6.04
15.83
1.1
1.1
—
—
—
0
0
28
48
6.04
15.83
1.1
1.1
—
—
—
0
0
28
48
6.04
15.83
1.1
1.1
—
—
—
0
0
234
1400
2.01
15.79
2.8
2.1
—
—
—
0
0
106
467
2.50
15.15
2.7
3.7
5.17
5.21
kpa
0.14
101
450
650
5672
3.30
14.52
32.7
15.7
40.85
25.91
mg/l
20.86
627
4623
207
3146
0.51
14.23
1.9
2.2
80.13
94.70
pmol/l
4.99
130
1630
150
2519
0.48
13.84
3.5
4.3
12.65
7.78
mg/mmol
0.55
95
1603
279
1835
1.87
13.80
4.3
4.0
0.00
0.01
estimate
0.50
117
577
27
53
5.26
13.25
1.1
1.2
—
—
—
0
0
41
116
3.69
12.73
1.3
1.3
—
—
—
0
0
43
126
3.57
12.68
1.3
1.3
—
—
—
0
0
37
98
3.93
12.60
1.2
1.3
—
—
—
0
0
12
0
+∞
12.53
1.0
0.0
—
—
—
0
0
23
22
10.77
12.33
1.4
1.4
—
—
—
0
0
25
49
5.26
12.29
1.1
1.2
—
—
—
0
0
31
76
4.22
11.70
2.0
1.8
90.66
90.20
%
0.23
31
76
25
52
4.95
11.51
2.6
2.5
64.84
58.14
%
0.94
19
42
210
1323
1.84
11.50
7.2
2.1
2.51
2.45
mmol/l
4.64
194
1171
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
55
202
2.87
11.20
2.1
2.4
0.38
0.36
iu/ml
0.14
41
117
23
47
5.03
10.80
1.3
1.4
—
—
—
0
0
511
5813
0.54
10.67
4.4
5.8
6.06
6.09
mmol/l
0.18
447
5261
169
1021
1.87
10.45
1.9
1.8
29.24
29.59
s
0.28
163
988
315
2280
1.70
10.40
3.3
3.2
—
—
—
0
0
469
5444
0.57
10.05
4.9
5.2
1.99
2.02
mu/l
0.15
415
4942
324
2379
1.68
10.02
4.9
4.0
0.02
0.02
estimate
0.06
122
512
27
68
4.09
9.85
1.3
1.4
—
—
—
0
0
36
111
3.37
9.85
1.3
1.3
—
—
—
0
0
142
848
1.85
8.98
3.9
4.6
1.00
1.03
mmol/l
0.56
134
770
103
554
2.01
8.90
2.3
1.6
65.05
66.95
g/l
1.67
92
505
19
40
4.86
8.63
1.4
1.3
—
—
—
0
0
213
1448
1.68
8.53
2.5
2.5
7.63
5.09
e6/l
1.58
199
1314
18
37
4.97
8.40
1.4
1.4
—
—
—
0
0
292
2179
1.59
7.89
2.3
2.3
207.98
263.69
u/l
0.52
275
2052
24
66
3.73
7.79
1.2
1.2
—
—
—
0
0
15
17
8.99
7.57
1.1
1.2
617.75
2.00
ug/l
—
9
6
53
1075
0.45
7.43
1.2
1.3
45.01
35.51
iu/ml
0.26
19
316
17
38
4.56
7.21
1.5
1.2
39.49
34.53
u/l
0.20
17
26
27
85
3.26
7.18
1.3
5.6
730.60
366.55
iu/ml
—
5
11
22
61
3.69
7.07
1.2
1.2
—
—
—
0
0
14
16
8.90
7.07
4.8
1.3
418.64
78.19
nmol/l
0.95
14
16
23
66
3.57
7.04
1.2
1.2
—
—
—
0
0
23
66
3.57
7.04
1.2
1.2
—
—
—
0
0
22
62
3.63
6.91
1.2
1.2
—
—
—
0
0
22
62
3.63
6.91
1.2
1.2
—
—
—
0
0
130
817
1.73
6.80
1.8
1.9
—
—
—
0
0
51
1018
0.46
6.80
1.1
1.3
10.17
13.09
u/ml
0.12
16
361
147
2136
0.60
6.75
1.6
1.7
16.67
20.25
nmol/l
2.10
123
1779
426
3535
1.53
6.73
3.4
3.2
98.49
48.78
u/l
3.94
397
3234
18
33
5.57
6.64
1.4
1.4
—
—
—
0
0
68
1208
0.52
6.40
1.1
1.3
1.20
1.43
u/ml
0.20
24
344
137
890
1.67
6.32
1.7
1.8
—
—
—
0
0
57
280
2.13
6.27
1.7
2.2
190.49
515.60
ug/l
1.24
52
264
44
197
2.32
6.05
1.3
1.3
—
—
—
0
0
220
1616
1.53
6.02
4.3
3.5
0.00
0.00
estimate
0.50
113
485
649
6040
2.15
5.99
34.7
20.1
137.75
139.81
mmol/l
44.77
636
5917
23
74
3.18
5.94
2.6
2.9
39.31
18.87
mg/l
0.80
16
24
649
6043
2.14
5.93
34.6
20.1
4.04
4.01
mmol/l
1.59
637
5911
12
15
8.12
5.85
1.3
1.1
—
—
—
0
0
9
7
13.00
5.59
1.6
1.7
2.11
2.33
ratio
—
9
7
214
2777
0.67
5.55
1.7
2.4
77.79
79.35
nmol/l
0.29
194
2436
298
2373
1.45
5.30
2.8
3.2
1560.75
1460.17
ng/l
0.16
267
2049
266
2074
1.46
5.28
3.2
3.2
618.12
103.93
e6/l
0.59
220
1581
14
26
5.47
5.24
1.2
1.1
—
—
—
0
0
14
26
5.47
5.24
1.2
1.1
—
—
—
0
0
14
26
5.47
5.24
1.2
1.1
—
—
—
0
0
14
26
5.47
5.24
1.2
1.1
—
—
—
0
0
232
1764
1.47
5.24
3.1
3.1
0.77
0.42
e6/l
1.59
197
1284
126
840
1.61
5.19
5.7
7.1
12.15
11.38
kpa
0.84
119
812
126
840
1.61
5.19
5.7
7.1
5.09
5.10
kpa
0.03
121
812
11
15
7.43
5.15
1.3
1.1
—
—
—
0
0
11
15
7.43
5.15
1.3
1.1
—
—
—
0
0
125
834
1.61
5.13
5.7
7.1
2.26
1.10
mmol/l
2.75
95
693
393
4518
0.70
4.97
4.5
4.0
15.44
15.01
pmol/l
2.45
351
4079
12
372
0.31
4.35
2.1
2.2
3.81
3.42
ratio
0.44
12
315
382
3257
1.38
4.27
4.6
4.0
0.00
0.02
estimate
1.20
137
599
649
6135
1.89
4.24
43.2
21.3
78.66
82.10
umol/l
2.07
638
6056
72
442
1.70
4.08
1.9
1.6
—
—
—
0
0
68
413
1.72
4.01
2.4
2.4
3.09
15.55
nmol/l
24.98
59
368
10
18
5.62
3.98
1.4
2.1
—
—
—
0
0
650
6178
1.82
3.71
47.8
23.9
92.19
91.75
fl
1.37
638
6091
14
39
3.64
3.71
1.3
1.1
—
—
—
0
0
650
6180
1.82
3.68
48.0
24.0
3.98
4.46
e12/l
85.27
629
6007
650
6180
1.82
3.68
48.2
24.4
36.35
40.32
%
74.59
639
6091
650
6180
1.82
3.68
48.0
24.0
254.35
239.83
e9/l
4.74
633
6032
650
6182
1.81
3.65
48.3
24.1
119.30
135.21
g/l
103.26
640
6094
638
6045
1.69
3.52
23.2
10.9
26.04
25.16
u/l
0.49
624
5807
226
1819
1.36
3.43
5.9
2.7
36.23
35.28
u/l
0.12
219
1709
61
382
1.65
3.24
5.5
3.6
46.66
47.81
%
0.13
61
373
21
91
2.35
3.20
4.1
6.4
8.77
7.84
mmol/l
0.36
16
78
366
3187
1.31
3.16
4.6
4.0
0.01
0.00
estimate
0.50
139
623
8
230
0.34
3.10
1.3
1.5
—
—
—
0
0
11
30
3.71
3.09
1.8
1.4
1.17
3.90
u/field
—
6
21
239
2847
0.76
3.06
2.4
2.4
—
—
—
0
0
29
149
1.99
2.94
1.4
1.2
—
—
—
0
0
19
83
2.33
2.86
1.6
1.3
—
—
—
0
0
368
3236
1.29
2.83
4.7
4.0
0.00
0.00
estimate
-0.00
142
642
7
206
0.33
2.83
1.3
1.5
—
—
—
0
0
35
198
1.81
2.69
1.3
1.3
1.43
1.39
ratio
0.07
21
119
213
1754
1.31
2.66
1.7
2.3
3.81
2.78
mg/l
4.36
188
1498
0
68
0.00
2.61
0.0
1.7
—
—
—
0
0
33
558
0.57
2.59
1.2
1.4
—
—
—
0
0
9
26
3.49
2.49
1.6
1.4
—
—
—
0
0
9
27
3.36
2.40
1.6
1.4
—
—
—
0
0
13
52
2.53
2.37
3.7
1.8
4.14
1.44
u/field
—
7
32
122
942
1.36
2.36
1.7
2.5
21.55
22.71
%
0.46
113
872
31
177
1.79
2.34
1.7
2.3
126.96
131.20
g/l
0.46
25
142
6
13
4.65
2.27
1.0
1.2
—
—
—
0
0
43
272
1.62
2.26
2.1
3.2
3.99
4.41
pmol/l
1.66
38
232
95
718
1.37
2.10
4.0
3.1
2.99
2.04
mmol/l
1.30
75
625
24
131
1.86
2.10
4.5
3.7
25.84
27.84
mg/l
0.08
12
93
81
596
1.41
2.10
6.4
7.0
1.55
1.42
mmol/l
0.46
81
588
11
43
2.58
2.08
1.4
1.4
—
—
—
0
0
6
161
0.37
2.04
1.2
1.2
—
—
—
0
0
17
83
2.07
2.02
3.9
2.4
1.21
1.18
mmol/l
0.43
17
83
136
1097
1.30
1.95
1.9
2.5
10.74
12.61
umol/l
2.73
129
1009
17
86
2.00
1.86
3.9
2.4
4.10
4.09
mmol/l
0.03
17
86
17
86
2.00
1.86
3.9
2.4
104.65
105.20
mmol/l
0.15
17
86
106
834
1.32
1.82
15.8
6.9
—
—
—
0
0
25
410
0.60
1.80
2.3
2.6
—
17.42
—
0
25
94
729
1.33
1.78
4.1
3.1
5.62
5.84
kpa
1.11
94
708
6
153
0.39
1.78
1.7
1.8
—
—
—
0
0
35
225
1.59
1.77
1.3
1.3
31.20
33.73
mg/l
0.11
25
194
6
18
3.35
1.75
1.5
1.4
—
—
—
0
0
6
18
3.35
1.75
1.5
1.4
—
—
—
0
0
35
226
1.58
1.74
1.3
1.3
39.90
44.86
mg/l
0.24
25
195
126
1022
1.28
1.73
1.7
2.5
2.08
2.26
g/l
2.69
119
939
22
362
0.59
1.62
1.2
1.4
—
48.07
—
0
25
29
183
1.61
1.60
4.1
2.9
1.91
1.54
mmol/l
0.51
29
176
79
619
1.31
1.42
2.6
2.3
11.24
7.61
umol/l
0.64
73
544
91
1120
0.78
1.37
3.5
2.9
1.50
1.19
e6/l
0.35
52
606
23
143
1.63
1.37
1.4
2.3
8.97
12.08
mg/l
1.31
18
133
239
2656
0.85
1.28
2.0
3.0
505.05
133.37
ug/l
8.17
219
2438
8
37
2.18
1.21
1.6
2.6
—
—
—
0
0
85
691
1.26
1.18
2.4
2.6
4.07
7.84
ug/l
3.42
71
610
13
223
0.57
1.17
1.0
1.1
—
—
—
0
0
433
4570
0.86
1.13
36.1
19.4
15.11
13.69
%
43.09
427
4493
10
51
1.97
1.11
2.0
2.3
—
—
—
0
0
14
81
1.74
1.09
3.9
6.4
10.04
12.45
mg/l
1.12
14
76
12
205
0.58
1.08
1.8
1.3
0.07
0.00
g/l
0.47
12
189
75
609
1.26
1.07
4.5
2.7
4.17
4.50
kpa
1.31
75
588
6
122
0.49
1.06
1.2
1.1
—
4.98
—
0
15
6
123
0.48
1.06
1.3
1.3
—
—
—
0
0
171
1518
1.17
0.98
1.8
1.8
418.69
25000437.16
pmol/l
1.21
144
1232
85
1013
0.82
0.98
3.8
3.1
0.60
1.97
e6/l
4.69
45
491
12
199
0.60
0.98
1.8
1.3
0.00
0.00
g/l
-0.00
12
180
40
517
0.76
0.92
1.4
1.7
1.88
1.60
%
0.42
31
428
41
528
0.76
0.92
1.2
1.5
—
—
—
0
0
9
153
0.58
0.89
1.2
1.2
—
9.76
—
0
10
20
136
1.48
0.87
1.0
1.3
—
338.33
—
0
12
141
1246
1.17
0.86
1.6
1.6
2.00
1.35
mg/l
1.08
113
965
52
641
0.80
0.84
1.4
1.4
—
—
—
0
0
12
190
0.63
0.84
1.1
1.6
8729.57
11140.27
e6/l
—
7
135
6
111
0.54
0.83
1.3
1.1
—
14.38
—
0
6
166
1491
1.15
0.82
5.2
4.3
1.02
1.02
kg/l
0.40
126
976
60
492
1.24
0.82
4.1
2.4
62.68
62.09
ml/min/173m2
0.04
19
204
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
122
1382
0.86
0.81
3.2
4.5
108.91
463.20
ng/l
3.82
96
1174
12
187
0.64
0.79
1.8
1.3
0.00
0.00
g/l
-0.00
12
179
0
25
0.00
0.79
0.0
1.1
—
1834.16
—
0
25
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
38.63
—
0
28
31
395
0.77
0.68
2.6
3.1
24.38
24.33
mmol/l
0.02
31
389
53
633
0.82
0.66
3.0
3.4
239.96
230.68
ng/l
0.06
47
590
543
5563
0.89
0.60
35.4
15.4
78.53
74.39
ml/min/173m2
5.02
519
5177
0
20
0.00
0.60
0.0
1.2
—
0.30
—
0
14
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.1
—
15.59
—
0
10
7
113
0.62
0.58
1.1
1.4
—
—
—
0
0
0
23
0.00
0.58
0.0
1.8
—
—
—
0
0
5
86
0.58
0.56
1.0
1.2
—
170.32
—
0
32
8
125
0.64
0.55
1.0
1.3
—
—
—
0
0
20
151
1.33
0.54
1.2
1.6
—
—
—
0
0
11
74
1.49
0.53
1.1
1.3
—
—
—
0
0
45
518
0.86
0.41
2.3
3.6
112.29
95.21
ng/l
0.22
38
443
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
439
4488
0.94
0.32
3.5
4.5
24.48
12.58
mm/h
18.43
390
4147
16
197
0.81
0.31
1.2
1.3
—
—
—
0
0
139
1312
1.07
0.30
2.0
1.8
1285.71
1206.36
nmol/l
0.46
114
997
8
110
0.72
0.29
1.0
1.4
—
—
—
0
0
16
131
1.23
0.27
1.4
2.0
261.50
198.70
%
1.28
16
122
9
75
1.20
0.25
1.6
1.4
—
—
—
0
0
6
85
0.70
0.24
1.0
1.2
—
—
—
0
0
18
152
1.19
0.24
1.1
1.1
—
—
—
0
0
18
152
1.19
0.24
1.1
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
146
1523
0.95
0.21
4.0
3.1
1.64
0.75
ug/l
4.30
115
1088
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
12
0.00
0.21
0.0
2.5
—
164.33
—
0
12
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
7.1
—
10.29
—
0
14
19
166
1.15
0.18
5.4
3.4
1.90
1.33
index
—
10
82
80
843
0.94
0.17
3.3
5.6
33.00
32.82
%
0.05
58
537
8
73
1.10
0.15
1.5
1.9
359.25
283.99
mu/l
—
8
65
16
140
1.15
0.15
1.2
1.6
—
—
—
0
0
159
1638
0.96
0.14
2.5
2.6
328.99
360.77
umol/l
3.08
135
1385
26
237
1.10
0.14
1.4
2.1
36.42
39.12
u/l
0.17
20
201
11
128
0.86
0.13
1.4
1.4
—
—
—
0
0
11
128
0.86
0.13
1.4
1.4
—
—
—
0
0
274
2694
1.03
0.12
9.6
4.5
19.36
2.09
ug/l
8.38
256
2406
27
290
0.93
0.10
1.1
1.2
177.66
106.37
u/ml
—
10
110
5
62
0.81
0.08
2.0
1.7
421.40
1095.74
mg
—
5
62
19
205
0.92
0.08
1.1
1.3
—
—
—
0
0
220
2184
1.01
0.03
6.8
4.2
24.35
24.09
%
0.08
147
1106
20
193
1.04
0.01
1.8
2.3
92.59
82.41
ug/min
—
9
116
5
52
0.96
0.00
1.2
1.1
—
—
—
0
0
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
8.35
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
23.23
—
0
8
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
0.14
—
0
9
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
108.22
—
0
9
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
117.60
—
0
5
8
80
1.00
-0.00
3.7
3.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
12.80
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SECONDARY_NAS – Secondary malignant neoplasm of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).